Worldwide experience with a totally subcutaneous implantable defibrillator: Early results from the EFFORTLESS S-ICD registry

European Heart Journal

Volumn 35, Issue 25, 2014, Pages 1657-1665

  Lambiase, Pier D ^a   Barr, Craig ^b   Theuns, Dominic A M J ^c   Knops, Reinoud ^d   Neuzil, Petr ^e   Johansen, Jens Brock ^f   Hood, Margaret ^g   Pedersen, Susanne ^c,h   Kääb, Stefan ⁱ   Murgatroyd, Francis ^j   Reeve, Helen L ^k   Carter, Nathan ^k   Boersma, Lucas ^l  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b RUSSELLS HALL HOSPITAL   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e Homnolka Hospital   (Czech Republic)

^f ODENSE UNIVERSITY HOSPITAL   (Denmark)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

^h TILBURG UNIVERSITY   (Netherlands)

ⁱ UNIVERSITY OF MUNICH   (Germany)

^j KING S COLLEGE HOSPITAL   (United Kingdom)

^k BOSTON SCIENTIFIC CORPORATION   (United States)

^l ST ANTONIUS HOSPITAL   (Netherlands)

more..

Author keywords

Cardiac arrest; Primary prevention; Secondary prevention; Subcutaneous ICD; Ventricular arrhythmias

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRADYCARDIA; CHILD; CONFUSION; DEVICE INFECTION; DISEASE SEVERITY; DIZZINESS; DYSPNEA; FAINTNESS; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEMATOMA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; OBSERVATIONAL STUDY; PLEURA EFFUSION; PNEUMOTHORAX; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECURRENT DISEASE; REGISTER; RETROSPECTIVE STUDY; SHOCK; TIME TO TREATMENT; ARRHYTHMIAS, CARDIAC; CLINICAL TRIAL; EVALUATION STUDY; MIDDLE AGED; PROCEDURES; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIAS, CARDIAC; CHILD; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS IMPLANTATION; QUALITY OF LIFE; REGISTRIES; TIME-TO-TREATMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903955123     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu112     Document Type: Article

References (38)

1. Santini M, Cappato R, Andresen D, Brachmann J, Davies DW, Cleland J, Filippi A, Gronda E, Hauer R, Steinbeck G, Steinhaus D. Current state of knowledge and experts' perspective on the subcutaneous implantable cardioverter-defibrillator. J Interv Card Electrophysiol 2009;25:83-88.
2. Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322-324.
3. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. Acomparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337: 1576-1583.
4. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Multicenter Automatic Defibrillator Implantation Trial (MADIT) Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
5. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Multicenter Automatic Defribbrilator Implantation Trial II (MADIT II) Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346: 877-883.
6. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, NcNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237.
7. Tung RT, Zimetbaum P, Josephson ME. A Critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008;52:1111-1121.
8. Olde Nordkamp LR, Wilde AA, Tijssen JG, Knops RE, van Dessel PF, de Groot JR. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention. Circ Arrhythm Electrophysiol 2013;6:91-100.
9. Reynolds MR, Cohen DJ, Kugelmass AD, Brown PP, Becker ER, Culler SD, Simon AW. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter defibrillators. J Am Coll Cardiol 2006;47:2493-2497.
10. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation 2007;115: 2474-2480.
11. Alter P, Waldhans S, Plachta E, Moosdorf R, Grimm W. Complications of implantable cardioverter defibrillator therapy in 440 Consecutive Patients. Pacing Clin Electrophysiol 2005;28:926-932.
12. Borleffs CJ, van Erven L, van Bommel RJ, van der Velde ET, van derWall EE, Bax JJ, Rosendaal FR, Schalij MJ. Risk of failure of transvenous implantable cardioverterdefibrillator leads. Circ Arrhythm Electrophysiol 2009;2:411-416.
13. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, Alexander ME, Triedman JK, Walsh EP, Friedman RA. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008;51:1685-1691.
14. Gradaus R, Wollmann C, Köbe J, Hammel D, Kotthoff S, Block M, Böcker D. Potential benefit from implantable cardioverter defibrillator therapy in children and young adolescents. Heart 2004;90:328-329.
15. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzet J, Neuzner J, Spitzer SG, Ardshev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 2010;363: 36-44.
16. Dabiri Abkenari L, Theuns DA, Valk SD, Van Belle Y, de Groot NM, Haitsma D, Muskens-Heemskerk A, Szili-Torok T, Jordaens L. Clinical experience with a novel subcutaneous implantable defibrillator system in a single center. Clin Res Cardiol 2011;100:737-744.
17. Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. J Am Coll Cardiol 2012;60:1933-1939.
18. Jarman J, Lascelles K, Wong T, Markides V, Clague J, Till J. Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J 2012;33:1351-1359.
19. Jarman JW, Todd DM. United Kingdomnational experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn. Europace 2013;15:1158-1165.
20. Aydin A, Hartel F, Schlüter M, Butter C, Köbe J, Seifert M, Gosau N, Hoffmann B, Hoffmann M, Vettorazzi E, Wilke I, Wegscheider K, Reichenspurner H, Eckardt L, Steven D, Willems S. Shock efficacy of subcutaneous implantable cardioverterdefibrillator for prevention of sudden cardiac death: initial multicenter experience. Circ Arrhythm Electrophysiol 2012;5:913-919.
21. Köbe J, Reinke F, Meyer C, Shin D, Martens E, Kääb S, Löher A, Amler S, Lichtenberg A, Winter J, Eckardt L. Implantable and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter casecontrol study. Heart Rhythm 2013;10:29-36.
22. Pedersen SS, Lambiase P, Boersma LV, Murgatroyd F, Johansen JB, Reeve H, Stuart AG, Adragao P, Theuns DA. Evaluation of factors impacting clinical outcome and cost effectiveness of the S-ICD: design and rationale of the EFFORTLESS S-ICD registry. Pacing Clin Electrophysiol 2012;35:574-579.
23. Krahn AD, Lee DS, Birnie D, Healy JS, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen A, Hardy J, Tu JV. Predictors of short-term complications after implantable cardioverter- defibrillator replacement: results from the Ontario ICD Database. Circ Arrhythm Electrophysiol. 2011;4: 136-142.
24. Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, Rashtian M, Kremers M, Crozier I, Lee KL, Smith W, Burke MC. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 2013;128:944-953.
25. Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Anderson J, Chung K, Wong WS, Mark DB, Lee KL, Bardy GH. SCD-HeFT Investigators. Nobenefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2008;52:551-556.
26. Kutyifa V, Huth Ruwald A-C, Aktas MK, Jons C, McNitt S, Polonsky B, Geller L, Merkely B, Moss AJ, Zareba W, Bloch Thomsen PE. Clinical Impact, Safety, and Efficacy of Single-versus Dual-Coil ICD Leads in MADIT-CRT. J Cardiovasc Electrophysiol 2013;24:1246-1252.
27. van Rees JB, de Bie MK, Thijssen J, Borleffs CJW, Schalij MJ, van Erven L. Implantationrelated complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. J Am Coll Cardiol 2011;58:995-1000.
28. Kirkfeldt RE, Johansen JB, Nohr EA, Moller M, Arnsbo P, Nielsen JC. Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28,860 Danish patients. Heart Rhythm 2011;8:1622-1628.
29. Hammill SC, Kremers MS, Stevenson LW, Heidenreich PA, Lang CM, Curtis JP, Wang Y, Berul CI, Kadish AH, Al-Khatib SM, Pina I, Walsh MN, Mirro MJ, Lindsay BD, Reynolds MR, Pontzer K, Blum L, Masoudi F, Rumsfeld J, Brindis RG. National ICD registry Annual Report 2009: review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm 2010;7:1340-1345.
30. Anderson KP. Estimates of implantable cardioverter-defibrillator complications: caveat emptor. Circulation 2009;119:1069-1071.
31. Brignole M. Are complications of implantable defibrillators under-estimated and benefits overestimated? Europace 2009;11:1129-1133.
32. Gold MR, Ahmad S, Browne K, Berg KC, Thackeray L, Berger RD. Prospective comparison of discrimination algorithms to prevent inappropriate ICD therapy: primary results of the Rhythm ID Going Head to Head Trial. Heart Rhythm 2012;9:370-377.
33. Gillian FR, Hayes DL, Boehmer JP, Day J, Heidenreich PA, Seth M, Jones PW, Stein KM, Saxon LA. Real world evaluation of dual-zone ICD and CRT-D programming compared to single-zone programming: the ALTITUDE REDUCES study. J Cardiovasc Electrophysiol 2011;22:1023-1029.
34. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK. PREPARE Investigators. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008;52:541-550.
35. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes NAM, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W. MADIT-RIT Investigators. Reduction of inappropriate therapy and mortality through ICD programming. N Engl J Med 2012;367: 2275-2283.
36. Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA, Wood MA, Burke MC. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol 2012;23:359-566.
37. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) Trial Results. Circulation 2004;110:2591-2596.
38. Olde Nordkamp LR, Knops RE, Bardy GH, Blaauw Y, Boersman LV, Bos JS, Delnoy PP, van Dessel PF, Driessen AH, de Groot JR, Herrman JP, Jordaens LJ, Kooiman KM, Maass AH, Meine M, Mizusawa Y, Molhock SG, van Opstal J, Tijssen JG, Wilde AA. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J 2012;163:753-760.e2.